Global Melanoma Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 123 pages | ID: G18677DB692GEN
GlobalInfoResearch

Abstracts

Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.

SCOPE OF THE REPORT:

This report studies the Melanoma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Melanoma market by product type and applications/end industries.
Confirmation of the clinical diagnosis is done with a skin biopsy. It is usually followed up with a wider excision of the scar or tumor. Depending on the stage, a sentinel lymph node biopsy may be performed. Treatment of advanced malignant melanoma is performed from a multidisciplinary approach.
The global Melanoma market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Melanoma.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Amgen
• Eristol-Mayers Squibb
• Eisai
• Roche
• Genetech
• Janssen Biotech
• Pfizer
• Novartis
• Vical
• Ziopharm

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Superficial Melanoma
• Nodular Melanoma
• Lentigo Maglina Melanoma
• Acral Lentigious

Market Segment by Applications, can be divided into

• Hospitals
• Pharmaceutical Companies
• Research Centres
• Clinics
• Laboratories

Contents

1 MELANOMA MARKET OVERVIEW

1.1 Product Overview and Scope of Melanoma
1.2 Classification of Melanoma by Types
  1.2.1 Global Melanoma Revenue Comparison by Types (2017-2023)
  1.2.2 Global Melanoma Revenue Market Share by Types in 2017
  1.2.3 Superficial Melanoma
  1.2.4 Nodular Melanoma
  1.2.5 Lentigo Maglina Melanoma
  1.2.6 Acral Lentigious
1.3 Global Melanoma Market by Application
  1.3.1 Global Melanoma Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Pharmaceutical Companies
  1.3.4 Research Centres
  1.3.5 Clinics
  1.3.6 Laboratories
1.4 Global Melanoma Market by Regions
  1.4.1 Global Melanoma Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Melanoma Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Melanoma Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Melanoma Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Melanoma Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Melanoma Status and Prospect (2013-2023)
1.5 Global Market Size of Melanoma (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Amgen
  2.1.1 Business Overview
  2.1.2 Melanoma Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Amgen Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eristol-Mayers Squibb
  2.2.1 Business Overview
  2.2.2 Melanoma Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Eristol-Mayers Squibb Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eisai
  2.3.1 Business Overview
  2.3.2 Melanoma Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Eisai Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
  2.4.1 Business Overview
  2.4.2 Melanoma Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Roche Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genetech
  2.5.1 Business Overview
  2.5.2 Melanoma Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Genetech Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.6 Janssen Biotech
  2.6.1 Business Overview
  2.6.2 Melanoma Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Janssen Biotech Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
  2.7.1 Business Overview
  2.7.2 Melanoma Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Pfizer Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
  2.8.1 Business Overview
  2.8.2 Melanoma Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Novartis Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.9 Vical
  2.9.1 Business Overview
  2.9.2 Melanoma Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Vical Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ziopharm
  2.10.1 Business Overview
  2.10.2 Melanoma Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Ziopharm Melanoma Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MELANOMA MARKET COMPETITION, BY PLAYERS

3.1 Global Melanoma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Melanoma Players Market Share
  3.2.2 Top 10 Melanoma Players Market Share
3.3 Market Competition Trend

4 GLOBAL MELANOMA MARKET SIZE BY REGIONS

4.1 Global Melanoma Revenue and Market Share by Regions
4.2 North America Melanoma Revenue and Growth Rate (2013-2018)
4.3 Europe Melanoma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Melanoma Revenue and Growth Rate (2013-2018)
4.5 South America Melanoma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Melanoma Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MELANOMA REVENUE BY COUNTRIES

5.1 North America Melanoma Revenue by Countries (2013-2018)
5.2 USA Melanoma Revenue and Growth Rate (2013-2018)
5.3 Canada Melanoma Revenue and Growth Rate (2013-2018)
5.4 Mexico Melanoma Revenue and Growth Rate (2013-2018)

6 EUROPE MELANOMA REVENUE BY COUNTRIES

6.1 Europe Melanoma Revenue by Countries (2013-2018)
6.2 Germany Melanoma Revenue and Growth Rate (2013-2018)
6.3 UK Melanoma Revenue and Growth Rate (2013-2018)
6.4 France Melanoma Revenue and Growth Rate (2013-2018)
6.5 Russia Melanoma Revenue and Growth Rate (2013-2018)
6.6 Italy Melanoma Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MELANOMA REVENUE BY COUNTRIES

7.1 Asia-Pacific Melanoma Revenue by Countries (2013-2018)
7.2 China Melanoma Revenue and Growth Rate (2013-2018)
7.3 Japan Melanoma Revenue and Growth Rate (2013-2018)
7.4 Korea Melanoma Revenue and Growth Rate (2013-2018)
7.5 India Melanoma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Melanoma Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MELANOMA REVENUE BY COUNTRIES

8.1 South America Melanoma Revenue by Countries (2013-2018)
8.2 Brazil Melanoma Revenue and Growth Rate (2013-2018)
8.3 Argentina Melanoma Revenue and Growth Rate (2013-2018)
8.4 Colombia Melanoma Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MELANOMA BY COUNTRIES

9.1 Middle East and Africa Melanoma Revenue by Countries (2013-2018)
9.2 Saudi Arabia Melanoma Revenue and Growth Rate (2013-2018)
9.3 UAE Melanoma Revenue and Growth Rate (2013-2018)
9.4 Egypt Melanoma Revenue and Growth Rate (2013-2018)
9.5 Nigeria Melanoma Revenue and Growth Rate (2013-2018)
9.6 South Africa Melanoma Revenue and Growth Rate (2013-2018)

10 GLOBAL MELANOMA MARKET SEGMENT BY TYPE

10.1 Global Melanoma Revenue and Market Share by Type (2013-2018)
10.2 Global Melanoma Market Forecast by Type (2018-2023)
10.3 Superficial Melanoma Revenue Growth Rate (2013-2023)
10.4 Nodular Melanoma Revenue Growth Rate (2013-2023)
10.5 Lentigo Maglina Melanoma Revenue Growth Rate (2013-2023)
10.6 Acral Lentigious Revenue Growth Rate (2013-2023)

11 GLOBAL MELANOMA MARKET SEGMENT BY APPLICATION

11.1 Global Melanoma Revenue Market Share by Application (2013-2018)
11.2 Melanoma Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Pharmaceutical Companies Revenue Growth (2013-2018)
11.5 Research Centres Revenue Growth (2013-2018)
11.6 Clinics Revenue Growth (2013-2018)
11.7 Laboratories Revenue Growth (2013-2018)

12 GLOBAL MELANOMA MARKET SIZE FORECAST (2018-2023)

12.1 Global Melanoma Market Size Forecast (2018-2023)
12.2 Global Melanoma Market Forecast by Regions (2018-2023)
12.3 North America Melanoma Revenue Market Forecast (2018-2023)
12.4 Europe Melanoma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Melanoma Revenue Market Forecast (2018-2023)
12.6 South America Melanoma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Melanoma Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Melanoma Picture
Table Product Specifications of Melanoma
Table Global Melanoma and Revenue (Million USD) Market Split by Product Type
Figure Global Melanoma Revenue Market Share by Types in 2017
Figure Superficial Melanoma Picture
Figure Nodular Melanoma Picture
Figure Lentigo Maglina Melanoma Picture
Figure Acral Lentigious Picture
Table Global Melanoma Revenue (Million USD) by Application (2013-2023)
Figure Melanoma Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Pharmaceutical Companies Picture
Figure Research Centres Picture
Figure Clinics Picture
Figure Laboratories Picture
Table Global Market Melanoma Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Melanoma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Melanoma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Melanoma Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Melanoma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Melanoma Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Melanoma Revenue (Million USD) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Melanoma Type and Applications
Table Amgen Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Eristol-Mayers Squibb Basic Information, Manufacturing Base and Competitors
Table Eristol-Mayers Squibb Melanoma Type and Applications
Table Eristol-Mayers Squibb Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Melanoma Type and Applications
Table Eisai Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Melanoma Type and Applications
Table Roche Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Genetech Basic Information, Manufacturing Base and Competitors
Table Genetech Melanoma Type and Applications
Table Genetech Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table Janssen Biotech Melanoma Type and Applications
Table Janssen Biotech Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Melanoma Type and Applications
Table Pfizer Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Melanoma Type and Applications
Table Novartis Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Vical Basic Information, Manufacturing Base and Competitors
Table Vical Melanoma Type and Applications
Table Vical Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Ziopharm Basic Information, Manufacturing Base and Competitors
Table Ziopharm Melanoma Type and Applications
Table Ziopharm Melanoma Revenue, Gross Margin and Market Share (2016-2017)
Table Global Melanoma Revenue (Million USD) by Players (2013-2018)
Table Global Melanoma Revenue Share by Players (2013-2018)
Figure Global Melanoma Revenue Share by Players in 2016
Figure Global Melanoma Revenue Share by Players in 2017
Figure Global Top 5 Players Melanoma Revenue Market Share in 2017
Figure Global Top 10 Players Melanoma Revenue Market Share in 2017
Figure Global Melanoma Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Melanoma Revenue (Million USD) by Regions (2013-2018)
Table Global Melanoma Revenue Market Share by Regions (2013-2018)
Figure Global Melanoma Revenue Market Share by Regions (2013-2018)
Figure Global Melanoma Revenue Market Share by Regions in 2017
Figure North America Melanoma Revenue and Growth Rate (2013-2018)
Figure Europe Melanoma Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Melanoma Revenue and Growth Rate (2013-2018)
Figure South America Melanoma Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Melanoma Revenue and Growth Rate (2013-2018)
Table North America Melanoma Revenue by Countries (2013-2018)
Table North America Melanoma Revenue Market Share by Countries (2013-2018)
Figure North America Melanoma Revenue Market Share by Countries (2013-2018)
Figure North America Melanoma Revenue Market Share by Countries in 2017
Figure USA Melanoma Revenue and Growth Rate (2013-2018)
Figure Canada Melanoma Revenue and Growth Rate (2013-2018)
Figure Mexico Melanoma Revenue and Growth Rate (2013-2018)
Table Europe Melanoma Revenue (Million USD) by Countries (2013-2018)
Figure Europe Melanoma Revenue Market Share by Countries (2013-2018)
Figure Europe Melanoma Revenue Market Share by Countries in 2017
Figure Germany Melanoma Revenue and Growth Rate (2013-2018)
Figure UK Melanoma Revenue and Growth Rate (2013-2018)
Figure France Melanoma Revenue and Growth Rate (2013-2018)
Figure Russia Melanoma Revenue and Growth Rate (2013-2018)
Figure Italy Melanoma Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Melanoma Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Melanoma Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Melanoma Revenue Market Share by Countries in 2017
Figure China Melanoma Revenue and Growth Rate (2013-2018)
Figure Japan Melanoma Revenue and Growth Rate (2013-2018)
Figure Korea Melanoma Revenue and Growth Rate (2013-2018)
Figure India Melanoma Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Melanoma Revenue and Growth Rate (2013-2018)
Table South America Melanoma Revenue by Countries (2013-2018)
Table South America Melanoma Revenue Market Share by Countries (2013-2018)
Figure South America Melanoma Revenue Market Share by Countries (2013-2018)
Figure South America Melanoma Revenue Market Share by Countries in 2017
Figure Brazil Melanoma Revenue and Growth Rate (2013-2018)
Figure Argentina Melanoma Revenue and Growth Rate (2013-2018)
Figure Colombia Melanoma Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Melanoma Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Melanoma Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Melanoma Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Melanoma Revenue Market Share by Countries in 2017
Figure Saudi Arabia Melanoma Revenue and Growth Rate (2013-2018)
Figure UAE Melanoma Revenue and Growth Rate (2013-2018)
Figure Egypt Melanoma Revenue and Growth Rate (2013-2018)
Figure Nigeria Melanoma Revenue and Growth Rate (2013-2018)
Figure South Africa Melanoma Revenue and Growth Rate (2013-2018)
Table Global Melanoma Revenue (Million USD) by Type (2013-2018)
Table Global Melanoma Revenue Share by Type (2013-2018)
Figure Global Melanoma Revenue Share by Type (2013-2018)
Figure Global Melanoma Revenue Share by Type in 2017
Table Global Melanoma Revenue Forecast by Type (2018-2023)
Figure Global Melanoma Market Share Forecast by Type (2018-2023)
Figure Global Superficial Melanoma Revenue Growth Rate (2013-2018)
Figure Global Nodular Melanoma Revenue Growth Rate (2013-2018)
Figure Global Lentigo Maglina Melanoma Revenue Growth Rate (2013-2018)
Figure Global Acral Lentigious Revenue Growth Rate (2013-2018)
Table Global Melanoma Revenue by Application (2013-2018)
Table Global Melanoma Revenue Share by Application (2013-2018)
Figure Global Melanoma Revenue Share by Application (2013-2018)
Figure Global Melanoma Revenue Share by Application in 2017
Table Global Melanoma Revenue Forecast by Application (2018-2023)
Figure Global Melanoma Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Pharmaceutical Companies Revenue Growth Rate (2013-2018)
Figure Global Research Centres Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Laboratories Revenue Growth Rate (2013-2018)
Figure Global Melanoma Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Melanoma Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Melanoma Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Melanoma Revenue Market Forecast (2018-2023)
Figure Europe Melanoma Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Melanoma Revenue Market Forecast (2018-2023)
Figure South America Melanoma Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Melanoma Revenue Market Forecast (2018-2023)